期刊
EJNMMI RADIOPHARMACY AND CHEMISTRY
卷 5, 期 1, 页码 -出版社
SPRINGERNATURE
DOI: 10.1186/s41181-020-0091-2
关键词
Automated production; Imaging; CXCR4; PentixaFor
类别
资金
- German Research Foundation (DFG)
- Open Access Publication Funds of Charite - Universitatsmedizin Berlin
BackgroundPentixaFor is a promising radiopharmaceutical for positron emission tomography in the detection of different tumor entities and other diseases. Until now, the synthesis of [Ga-68]Ga-PentixaFor was reported for the automated synthesis module from Scintomics (R) only. Our aim was to evaluate the automated synthesis of this radiopharmaceutical on a different module in order to make it available for a broader community.ResultsThe synthesis of [Ga-68]Ga-PentixaFor with different amounts of PentixaFor (50 mu g, 30 mu g and 20 mu g) on the Modular Lab PharmTracer (MLPT) from Eckert & Ziegler with the already established synthesis template for [Ga-68]Ga-DOTATOC yielded best results with 50 mu g PentixaFor for clinical multi-dose application. All different quality control parameters tested (e.g. sterility, stability and radiochemical purity) were in accordance with the European Pharmacopoeia.Conclusions[Ga-68]Ga-PentixaFor was successfully synthesized fully-automated on the synthesis module Modular Lab PharmTracer and can be used for multi-dose application in clinical settings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据